Syrhatech completes a financinground of CHF 4.5 million
Plan-les-Ouates, Geneva, April 2025 – Syrhatech, a French-Swiss CDMO innovating in thedevelopment and manufacture of…

Plan-les-Ouates, Geneva, April 2025 – Syrhatech, a French-Swiss CDMO innovating in thedevelopment and manufacture of…
As we step into the New Year, SyrhaTech is excited to announce a significant addition…
No company is more future-oriented at the moment than SyrhaTech: a Biotech medical device company…
For the past four months, SyrhaTech has been in partnership with the learned society ISHAS…
The SyrhaTech team is made up of people from Europe’s four corners. Everyone is very…
SyrhaTech is proud to announce that we have joined the “CDMO France” association. CDMO France…
At SyrHA, we believe that the cornerstone of our success is the unwavering trust that…
We are pleased to inform you that SyrHA has joined the International Society for Hyaluronic…
Innovative biopharmaceutical companies are increasingly engaging in strategic partnerships with CDMOs, whereas in the past,…